Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

A Venditti; L Maurillo; F Buccisano; G Del Poeta; C Mazzone; A Tamburini; M I Del Principe; M I Consalvo; P De Fabritiis; L Cudillo; A Picardi; A Franchi; F L Coco; S Amadori

首页> 外文期刊>Leukemia >Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

【24h】

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

机译：移植前最小残留疾病水平可预测接受大剂量化学疗法和自体干细胞移植的急性髓样白血病患者的临床结局

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia》 |2004年第2期|共1页
作者
A Venditti; L Maurillo; F Buccisano; G Del Poeta; C Mazzone; A Tamburini; M I Del Principe; M I Consalvo; P De Fabritiis; L Cudillo; A Picardi; A Franchi; F L Coco; S Amadori;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation [J] . A Venditti, L Maurillo, F Buccisano, Leukemia . 2003,第11期

机译：移植前最小残留疾病水平可预测接受大剂量化学疗法和自体干细胞移植的急性髓样白血病患者的临床结局
2. The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy | Haematologica [J] . E Laane, AR Derolf, E Bjorklund, Haematologica . 2006,第6期

机译：缓解后化疗后，通过流式细胞术检测异基因干细胞移植对年轻急性髓样白血病患者的预后的影响血液学
3. Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemia [J] . Mingzhu Xua, Hong Liu, Yuejun Liu, Leukemia and lymphoma . 2019,第11a12期

机译：基因突变和预挥发膜最小的残留疾病预测成年血管生效性干细胞移植治疗T细胞急性淋巴细胞白血病后成人患者复发风险
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Posttraumatic stress disorder and sub-syndromal trauma symptoms in cancer patients treated with autologous hematopoietic stem cell transplant and standard dose chemotherapy. [D] . Gourvitz, Ross L. 2008

机译：自体造血干细胞移植和标准剂量化疗治疗的癌症患者的创伤后应激障碍和综合征下创伤症状。
6. Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia [O] . Alvaro de Santiago de Benito, Barbara Jeker, Eva Gfeller, 2020

机译：分子最小残留疾病阴性和降低的干细胞动员潜力预测自体移植后NPM1突变急性髓性白血病的优异结果
7. Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation [O] . Venditti, A, Maurillo, L, Buccisano, F, 2003

机译：移植前最小残留疾病水平预测接受大剂量化疗和自体干细胞移植的急性髓样白血病患者的临床结局

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

著录项

相似文献

相关主题

期刊订阅